326 related articles for article (PubMed ID: 36359260)
1. Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art.
Luzzi S; Cherubini V; Falsetti L; Viticchi G; Silvestrini M; Toraldo A
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359260
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies.
Zhou F; Chen S
Ageing Res Rev; 2019 May; 51():55-66. PubMed ID: 30826501
[TBL] [Abstract][Full Text] [Related]
3. Levels of Vitamins and Homocysteine in Older Adults with Alzheimer Disease or Mild Cognitive Impairment in Cuba.
Lanyau-Domínguez Y; Macías-Matos C; Jesús J; María G; Suárez-Medina R; Eugenia M; Noriega-Fernández L; Guerra-Hernández M; Calvo-Rodríguez M; Sánchez-Gil Y; García-Klibanski M; Herrera-Javier D; Arocha-Oriol C; Díaz-Domínguez M
MEDICC Rev; 2020 Oct; 22(4):40-47. PubMed ID: 33295319
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
Raszewski G; Chwedorowicz R; Chwedorowicz A; Gustaw Rothenberg K
Ann Agric Environ Med; 2016; 23(1):193-6. PubMed ID: 27007541
[TBL] [Abstract][Full Text] [Related]
5. Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model.
Verma N; Gupta JK; Varshney KK; Srivastava R
Drug Metab Lett; 2021; 14(3):219-231. PubMed ID: 34886786
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine as a biomarker for cognitive dysfunction in the elderly.
Schulz RJ
Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):718-23. PubMed ID: 18089953
[TBL] [Abstract][Full Text] [Related]
7. The worldwide challenge of the dementias: a role for B vitamins and homocysteine?
Smith AD
Food Nutr Bull; 2008 Jun; 29(2 Suppl):S143-72. PubMed ID: 18709889
[TBL] [Abstract][Full Text] [Related]
8. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?
Zoccolella S; Lamberti SV; Iliceto G; Santamato A; Lamberti P; Logroscino G
Curr Med Chem; 2010; 17(28):3253-61. PubMed ID: 20666719
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden.
Reffo A; Gabelli C
J Geriatr Psychiatry Neurol; 2022 Jan; 35(1):57-61. PubMed ID: 33461371
[TBL] [Abstract][Full Text] [Related]
11. Association between homocysteine levels and cognitive profile in Alzheimer's Disease.
Luzzi S; Papiri G; Viticchi G; Baldinelli S; Fiori C; Silvestrini M; Toraldo A
J Clin Neurosci; 2021 Dec; 94():250-256. PubMed ID: 34863447
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine, B Vitamins, and Cognitive Impairment.
Smith AD; Refsum H
Annu Rev Nutr; 2016 Jul; 36():211-39. PubMed ID: 27431367
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease.
Wong A; Mok V; Fan YH; Lam WW; Liang KS; Wong KS
J Neurol; 2006 Apr; 253(4):441-7. PubMed ID: 16267639
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine in neuropsychiatric disorders of the elderly.
Reutens S; Sachdev P
Int J Geriatr Psychiatry; 2002 Sep; 17(9):859-64. PubMed ID: 12221661
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and Dementia: An International Consensus Statement.
Smith AD; Refsum H; Bottiglieri T; Fenech M; Hooshmand B; McCaddon A; Miller JW; Rosenberg IH; Obeid R
J Alzheimers Dis; 2018; 62(2):561-570. PubMed ID: 29480200
[TBL] [Abstract][Full Text] [Related]
16. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.
Dayon L; Guiraud SP; Corthésy J; Da Silva L; Migliavacca E; Tautvydaitė D; Oikonomidi A; Moullet B; Henry H; Métairon S; Marquis J; Descombes P; Collino S; Martin FJ; Montoliu I; Kussmann M; Wojcik J; Bowman GL; Popp J
Alzheimers Res Ther; 2017 Jun; 9(1):43. PubMed ID: 28623948
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
Lauriola M; D'Onofrio G; Ciccone F; Germano C; Cascavilla L; Paris F; Greco A
J Alzheimers Dis; 2021; 82(1):235-248. PubMed ID: 34057086
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia, related vitamins and dementias.
Delport R
J Nutr Health Aging; 2000; 4(4):195-6. PubMed ID: 11115799
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
Farina N; Jernerén F; Turner C; Hart K; Tabet N
Exp Gerontol; 2017 Dec; 99():146-150. PubMed ID: 29024723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
